$4.220
+0.020 (+0.48%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ARTV Prediction & Forecast by Similar Chart Analysis
Alphio's ARTV stock price prediction model matches the current Artiva Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.21 (-0.20%). The 1-week path is $4.30 (+1.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Artiva Biotherapeutics Inc Stock?
Artiva Biotherapeutics is not a good buy right now due to significant financial losses and recent downgrades by analysts. The current price is $4.19, which is near the downgraded price target of $4 from Jefferies and Wedbush. The RSI is extremely low at 12.93, indicating oversold conditions, but the company's ongoing net losses, which reached $23.5 million in Q1 2026, and the discontinuation of its lead program due to safety concerns, present substantial risks. The main risk is the potential for further declines in share price given the negative sentiment and recent analyst downgrades.
ARTV stock price ended at $4.22 on Wednesday, after rising +0.48%
Artiva Biotherapeutics Inc (ARTV) last closed at $4.2199998, gaining +0.48%. These facts feed the 1-day and 1-week ARTV price prediction above.
Forecast Drivers
Artiva Biotherapeutics Inc (ARTV) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ARTV, ranked by similarity.
Seasonality analysis for ARTV
Historically the probability of a positive November return for ARTV is 18.60%. June offers the highest probability of a positive month at 51.22%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ARTV
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.11 | $2.54 | $2.64 | -39.81% |
| Dec 2026 | $2.58 | $2.89 | $3.02 | -31.61% |
In 2026, Artiva Biotherapeutics Inc (ARTV) is projected to range from $2.11 to $3.02.
Artiva Biotherapeutics Inc 2026 monthly forecast
In Nov 2026, Artiva Biotherapeutics Inc is projected to average $2.54, with a low of $2.11 and high of $2.64.
In Dec 2026, Artiva Biotherapeutics Inc is projected to average $2.89, with a low of $2.58 and high of $3.02.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.